Patient Involvement in the Design of a Phase III Trial Comparing Intensity-modulated Proton Therapy and Intensity-modulated Radiotherapy for Oropharyngeal Cancer.

Hague, C; Foran, B; Hall, E; Guild, S; Joseph, O; Moule, R; Nutting, C; Parsons, S; Prestwich, R; Slevin, N; West, C; Thomson, D

Hague, C; Foran, B; Hall, E; Guild, S; Joseph, O; Moule, R; Nutting, C; Parsons, S; Prestwich, R; Slevin, N; West, C; Thomson, D.

Affiliation

Hague C; The Christie NHS Foundation Trust, Manchester, UK.
Foran B; Weston Park Hospital, Sheffield, UK.
Hall E; The Institute of Cancer Research, Clinical Trials and Statistics Unit, London, UK.
Guild S; Patient Representative, Leeds, UK.
Joseph O; Manchester University NHS Foundation Trust, The University of Manchester, Public Programmes Team, Manchester, UK.
Moule R; The University College London Hospital, London, UK.
Nutting C; The Royal Marsden NHS Foundation Trust, London, UK.
Parsons S; Manchester University NHS Foundation Trust, The University of Manchester, Public Programmes Team, Manchester, UK.
Prestwich R; St James' University Hospital, Leeds, UK.
Slevin N; The Christie NHS Foundation Trust, Manchester, UK.
West C; Division of Cancer Science, The University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, Manchester, UK.
Thomson D; The Christie NHS Foundation Trust, Manchester, UK. Electronic address: david.thomson@christie.nhs.uk.

Clin Oncol (R Coll Radiol) ; 30(5): 274-276, 2018 05.

Article in En | MEDLINE | ID: mdl-29459100

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Clin Oncol (R Coll Radiol) Journal subject: NEOPLASIAS Year: 2018 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google